COaching and Prehabilitation: Faisability Study in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
NCT03595787 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2024-12-18
Summary
This faisability study aims to evaluate the adhesion of the patient to a multidisciplinary program (adapted physical activity, coaching and nutrition)
Conditions
Interventions
- PROCEDURE
-
Coaching and Habilitation
nutritional support, adapted physical activity and coaching
Sponsors & Collaborators
-
Institut Paoli-Calmettes
lead OTHER
Principal Investigators
-
Cécile Bannier Braticevic, MD · Institut Paoli-Calmettes
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-04
- Primary Completion
- 2025-05-04
- Completion
- 2025-05-04
Countries
- France
Study Locations
More Related Trials
-
Impact of Cross-training on Induction Treatment Response in Acute Lymphoblastic Leukemia Adults
NCT05059847 ·Status: UNKNOWN ·Phase: NA
-
Study of Management and Prognosis of Patients With Acute Myeloblastic Leukemia in Saint-Antoine Hospital
NCT05558943 ·Status: NOT_YET_RECRUITING
-
Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy
NCT01235572 ·Status: COMPLETED ·Phase: PHASE2
-
Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy
NCT01170598 ·Status: COMPLETED ·Phase: PHASE2
-
TMLI Plus Chemotherapy in High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
NCT06598969 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Oligoblastic AML
NCT04061239 ·Status: RECRUITING ·Phase: PHASE2
-
Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia
NCT02842112 ·Status: COMPLETED
-
Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid Hemopathy
NCT01819558 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of Adult ALL With an MRD-directed Programme.
NCT00358072 ·Status: COMPLETED ·Phase: PHASE2
-
Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy
NCT03603795 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT00499785 ·Status: COMPLETED
-
Management of Mixed-Phenotype Acute Leukemia in the East of France
NCT03599869 ·Status: UNKNOWN
-
Interplay Between Immune and Metabolic Programs in Myelodysplastic Syndromes
NCT04803721 ·Status: COMPLETED
-
Evaluation of a Question Prompt List for Patients With Myelodysplastic Syndromes (QPL-MDS)
NCT02781441 ·Status: UNKNOWN ·Phase: NA
-
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
NCT06459024 ·Status: RECRUITING
-
Study of the Outcome of Patients With Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Receiving Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
NCT03659084 ·Status: UNKNOWN
-
Cohort Study Assessing the Treatment Strategy for High-Risk Myelodysplastic Syndromes in Patients Under 70
NCT05367583 ·Status: UNKNOWN
-
Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment)
NCT02085798 ·Status: COMPLETED
-
Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid Leukemia in First Remission
NCT00150878 ·Status: TERMINATED ·Phase: PHASE3
-
DNR and AraC Combined to Fractionated Mylotarg® in Patients With First Relapse of AML
NCT02182596 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60
NCT02234037 ·Status: TERMINATED ·Phase: PHASE1
-
Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
NCT00322101 ·Status: COMPLETED ·Phase: PHASE3
-
Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes
NCT04861207 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML
NCT03597321 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
NCT06956755 ·Status: RECRUITING